title: Analysis of multiple endpoints in clinical trials: it's time for the designations of primary, secondary and tertiary to go.
authors.affiliation: Amgen, Department of Global Biostatistics and Epidemiology, Thousand Oaks, CA 91320, USA. ssnapinn@amgen.com
authors.forename: Steven
authors.initials: S
authors.lastname: Snapinn
authors.forename: Qi
authors.initials: Q
authors.lastname: Jiang
mesh_terms: D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D006801:Humans; D012107:Research Design; D013223:Statistics as Topic / Q000379:methods*